Oral mucositis - 15/08/11
Doi : 10.1016/j.cden.2004.07.009
Rajesh V. Lalla, BDS, PhD a, ⁎ 
, Douglas E. Peterson, DMD, PhD b
, Douglas E. Peterson, DMD, PhD b a Division of Oral Medicine, Department of Oral Diagnosis, University of Connecticut School of Dental Medicine, 263 Farmington Avenue, Farmington, CT 06030, USA
b Cancer Center, University of Connecticut Health Center, 263 Farmington Avenue, Farmington, CT 06030, USA
Corresponding author.Plan
| This work was supported by Grant No. T32DE07302 from the National Institutes of Health. Dr. Lalla has no financial relationships with the makers of any of the products discussed in this article. Dr. Peterson serves as paid consultant for the following companies: Aesgen Inc., Endo Pharmaceuticals, McNeil Consumer & Specialty Pharmaceuticals, and OSI Pharmaceuticals. |
© 2004
Elsevier Inc. Tous droits réservés.
Vol 49 - N° 1
P. 167-184 - janvier 2005 Retour au numéro
Article précédent
- Oral cancer: leukoplakia and squamous cell carcinoma
- Nelson L. Rhodus
- Pigmented lesions of the oral cavity
- Craig L. Hatch
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?